Literature DB >> 3469217

Constitutive and inducible secretion of platelet-derived growth factor analogs by human leukemic cell lines coexpressing erythroid and megakaryocytic markers.

T Papayannopoulou, E Raines, S Collins, B Nakamoto, M Tweeddale, R Ross.   

Abstract

We have examined the constitutive and inducible secretion of platelet-derived growth factor (PDGF)-like proteins in a variety of human hemopoietic cell lines. The highest levels of secreted protein were noted in four human erythroleukemia lines which, in addition to erythroid lineage markers, express one or more megakaryocytic lineage markers. Induction of these lines by 12-O-tetradecanoylphorbol-13-acetate enhanced the expression of megakaryocytic markers and increased secretion of PDGF-like proteins several fold. In concert with these changes, there was significant induction of c-sis/PDGF-B messenger RNA (mRNA) expression in all lines, whereas one line showed significant concurrent induction of PDGF-A mRNA expression. Whether PDGF-like secretion is part of the stem cell-like phenotype displayed by these lines or is secondary to their leukemic transformation remains to be determined. Nevertheless, these lines provide new cellular models for studying the expression and function of PDGF analogs in hemopoietic cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3469217      PMCID: PMC424221          DOI: 10.1172/JCI112895

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

1.  HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression.

Authors:  P Martin; T Papayannopoulou
Journal:  Science       Date:  1982-06-11       Impact factor: 47.728

2.  Cultured endothelial cells produce a platelet-derived growth factor-like protein.

Authors:  P E DiCorleto; D F Bowen-Pope
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

3.  Production of platelet-derived growth factor-like molecules and reduced expression of platelet-derived growth factor receptors accompany transformation by a wide spectrum of agents.

Authors:  D F Bowen-Pope; A Vogel; R Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

4.  The surface antigen profile of HEL cells.

Authors:  T Papayannopoulou; T Yokochi; B Nakamoto; P Martin
Journal:  Prog Clin Biol Res       Date:  1983

5.  Membrane proteins on human megakaryocytes and platelets identified by monoclonal antibodies.

Authors:  P Thiagarajan; B Perussia; L De Marco; K Wells; G Trinchieri
Journal:  Am J Hematol       Date:  1983-05       Impact factor: 10.047

6.  Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor.

Authors:  B S Coller; E I Peerschke; L E Scudder; C A Sullivan
Journal:  Blood       Date:  1983-01       Impact factor: 22.113

7.  Myeloid and megakaryocytic properties of K-562 cell lines.

Authors:  A Tabilio; P G Pelicci; G Vinci; P Mannoni; C I Civin; W Vainchenker; U Testa; M Lipinski; H Rochant; J Breton-Gorius
Journal:  Cancer Res       Date:  1983-10       Impact factor: 12.701

8.  The molecular biology of platelet-derived growth factor.

Authors:  C D Stiles
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

9.  Human erythroleukemia cell line (HEL) undergoes a drastic macrophage-like shift with TPA.

Authors:  T Papayannopoulou; B Nakamoto; T Yokochi; A Chait; R Kannagi
Journal:  Blood       Date:  1983-10       Impact factor: 22.113

10.  Expression of platelet membrane glycoproteins and alpha-granule proteins by a human erythroleukemia cell line (HEL).

Authors:  A Tabilio; J P Rosa; U Testa; N Kieffer; A T Nurden; M C Del Canizo; J Breton-Gorius; W Vainchenker
Journal:  EMBO J       Date:  1984-02       Impact factor: 11.598

View more
  16 in total

Review 1.  The role of colony-stimulating factors in acute leukemia.

Authors:  F Herrmann; E Vellenga
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Platelet-derived growth factor (PDGF) in plasma of breast cancer patients: correlation with stage and rate of progression.

Authors:  S Ariad; L Seymour; W R Bezwoda
Journal:  Breast Cancer Res Treat       Date:  1991-12       Impact factor: 4.872

3.  Regulation of megakaryocyte phenotype in human erythroleukemia cells.

Authors:  M W Long; C H Heffner; J L Williams; C Peters; E V Prochownik
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

4.  Regulation of expression of the c-sis proto-oncogene.

Authors:  L Ratner
Journal:  Nucleic Acids Res       Date:  1989-06-12       Impact factor: 16.971

5.  Platelet glycoprotein IIb. Chromosomal localization and tissue expression.

Authors:  P F Bray; J P Rosa; G I Johnston; D T Shiu; R G Cook; C Lau; Y W Kan; R P McEver; M A Shuman
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

6.  Characterization of biologically active, platelet-derived growth factor-like molecules produced by murine erythroid cells in vitro and in vivo.

Authors:  A J Sytkowski; C O'Hara; G Vanasse; M J Armstrong; S Kreczko; N Dainiak
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

7.  Proteoglycan synthesis in human erythroleukaemia (HEL) cells.

Authors:  B P Schick; S Senkowski-Richardson
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

8.  Regulated production of a pleiotropic cytokine-platelet-derived growth factor--by differentiating erythroid cells in vitro and in vivo.

Authors:  J C Keutzer; A J Sytkowski
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

9.  Platelet-derived growth factor A chain: gene structure, chromosomal location, and basis for alternative mRNA splicing.

Authors:  D T Bonthron; C C Morton; S H Orkin; T Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

10.  GATA and Ets cis-acting sequences mediate megakaryocyte-specific expression.

Authors:  V Lemarchandel; J Ghysdael; V Mignotte; C Rahuel; P H Roméo
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.